Franziska Maria Zickgraf
BASF (Germany)(DE)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Cancer Cells and Metastasis, Gut microbiota and health, Glycosylation and Glycoproteins Research, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma(2016)226 cited
- → Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations(2017)195 cited
- → The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features(2015)82 cited
- → Investigating the gut microbiome and metabolome following treatment with artificial sweeteners acesulfame potassium and saccharin in young adult Wistar rats(2022)24 cited
- → Demonstrating the reliability of in vivo metabolomics based chemical grouping: towards best practice(2024)13 cited
- → Engineered nanomaterials and the microbiome: Implications for human health(2023)7 cited
- → A high-throughput metabolomics in vitro platform for the characterization of hepatotoxicity(2023)7 cited
- → A metabolomics approach to reveal the mechanism of developmental toxicity in zebrafish embryos exposed to 6-propyl-2-thiouracil(2023)7 cited
- → Connecting Gut Microbial Diversity with Plasma Metabolome and Fecal Bile Acid Changes Induced by the Antibiotics Tobramycin and Colistin Sulfate(2023)7 cited
- → Application of high throughput in vitro metabolomics for hepatotoxicity mode of action characterization and mechanistic-anchored point of departure derivation: a case study with nitrofurantoin(2023)5 cited